Fine, Kaplan and Black, R.P.C.宣布，若您曾于2009年5月1日至2019年12月31日期间在美国境内支付或报销过特定处方仿制药费用，现可提交集体诉讼和解索赔表

Neutral

AI Analysis

Summary

Fine, Kaplan and Black, R.P.C. announces a class action settlement regarding generic drug payments made between May 1, 2009 and December 31, 2019 in the United States. Eligible parties can submit settlement claims.

Importance:1/10

Sentiment:

0.00

LegalClass Action SettlementGeneric DrugsAntitrust

Related Companies

$BDTX

Read the original article

Published by PR Newswire Pharma on July 10, 2026 9:00 PM

Read Original